BFM
ETNB

Boothbay Fund Management’s 89bio ETNB Stock Holding History

Boothbay Fund Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,930
Closed -$254K – 1549
2025
Q1 		$254K Buy
+34,930
New +$305K 0.01% 1101
2023
Q2 		– Sell
-10,779
Closed -$164K – 1948
2023
Q1 		$164K Sell
10,779
-77,756
-88% -$1.01M ﹤0.01% 1800
2022
Q4 		$1.13M Buy
88,535
+52,775
+148% +$475K 0.03% 839
2022
Q3 		$207K Buy
+35,760
New +$157K 0.01% 1823
2020
Q4 		– Sell
-39,104
Closed -$1M – 1282
2020
Q3 		$1M Buy
+39,104
New +$1.24M 0.06% 426

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boothbay Fund Management's ETNB Position: Q2 2025 in Review

Boothbay Fund Management sold out of 89bio (ETNB) in Q2 2025, closing a stake of 34,930 shares — an estimated $254K sold.

Boothbay Fund Management first reported a position in ETNB in Q3 2020 and held it in 5 quarters. The position peaked at $1.13M in Q4 2022. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Boothbay Fund Management reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 34,930 89bio shares in Q2 2025, an estimated $254K.
  • Boothbay Fund Management first reported a position in 89bio in Q3 2020 and held it in 5 quarters.
  • Boothbay Fund Management's 89bio position peaked at $1.13M in Q4 2022.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.